United States medical technology enterprise Elidah, based in Connecticut, has expanded the availability of noninvasive pelvic therapies with its wearable neuromuscular stimulation platform designed to treat stress urinary incontinence and pelvic floor weakness. Founded by American medical device innovators Gloria Kolb and Eric Kolb, the company developed an external treatment patch that delivers targeted therapeutic pulses without requiring internal probes or invasive clinical procedures.
The surface applied patch utilizes precision transcutaneous neuromuscular stimulation to activate the pelvic musculature directly through the skin. Worn discreetly beneath everyday clothing, the device produces automated contractions that replicate traditional physical therapy exercises at an intensity and consistency that patients often struggle to achieve independently. By stimulating the pudendal nerve pathways and surrounding supporting tissues, the system trains neuromuscular memory and restores tone to weakened muscles.
Pelvic floor dysfunction affects hundreds of millions of people worldwide, yet conventional treatment options have historically created steep barriers to consistent care. Many patients avoid treatment entirely due to the discomfort of internal vaginal probes, long waits for specialized therapy clinics, or hesitation surrounding surgical mesh implants. Gloria Kolb and Eric Kolb engineered the wearable system to operate entirely externally, allowing users to undergo comprehensive twenty minute treatment sessions at home while continuing routine daytime activities.
Clinical trials evaluating the external stimulation patch showed significant reductions in leakage episodes along with substantial improvements in muscle endurance and quality of life metrics within six weeks of daily use. Because the device is cleared for over the counter distribution, patients can bypass prolonged specialist referrals and access effective intervention early in the progression of symptoms.
The founders emphasized that destigmatizing pelvic health care requires both accessible engineering and patient centered design. With regulatory clearances broadening into international markets, the United States company plans to introduce next generation smart variants featuring connected mobile tracking to assist individuals in monitoring therapeutic progress and rebuilding long term pelvic strength.